Imported Disease Annotations - CTDObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | FDX2 | Human | mitochondrial myopathy | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | | |
|
Imported Disease Annotations - CTDObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | FDX2 | Human | mitochondrial myopathy | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | Iron-sulfur cluster biogenesis in mammalian cells: New insights into the molecular mechanisms of cluster delivery. | Maio N and Rouault TA, Biochim Biophys Acta. 2015 Jun;1853(6):1493-512. doi: 10.1016/j.bbamcr.2014.09.009. Epub 2014 Sep 19. |
2. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
3. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:2340092 | PMID:12477932 | PMID:14702039 | PMID:16344560 | PMID:20301403 | PMID:20547883 | PMID:20877624 | PMID:21832049 | PMID:21873635 | PMID:22101253 | PMID:23208207 | PMID:24281368 |
PMID:25416956 | PMID:27519411 | PMID:28001042 | PMID:28514442 | PMID:29097656 | PMID:30010796 | PMID:31395877 | PMID:31536960 | PMID:32296183 | PMID:33961781 | PMID:34373451 | PMID:34800366 |
PMID:36280795 | PMID:37704626 |
FDX2 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fdx2 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fdx2 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fdx2 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FDX2 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FDX2 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LOC101962614 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FDX2 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fdx2 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in FDX2
119 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
NM_001397406.1(FDX2):c.1A>T (p.Met1Leu) | single nucleotide variant | Inborn mitochondrial myopathy [RCV000853480]|Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy [RCV003883133]|Mitochondrial myopathy, episodic, without optic atrophy and reversible leukoencephalopathy [RCV001777150]|not provided [RCV001857471] | Chr19:10315996 [GRCh38] Chr19:10426672 [GRCh37] Chr19:19p13.2 |
pathogenic|uncertain significance |
GRCh38/hg38 19p13.2-13.13(chr19:8831147-13331227)x3 | copy number gain | See cases [RCV000052908] | Chr19:8831147..13331227 [GRCh38] Chr19:8941823..13442041 [GRCh37] Chr19:8802823..13303041 [NCBI36] Chr19:19p13.2-13.13 |
likely pathogenic |
GRCh38/hg38 19p13.2-13.12(chr19:10315258-14048994)x3 | copy number gain | See cases [RCV000052909] | Chr19:10315258..14048994 [GRCh38] Chr19:10425934..14159806 [GRCh37] Chr19:10286934..14020806 [NCBI36] Chr19:19p13.2-13.12 |
pathogenic |
NM_001031734.3(FDX1L):c.26C>A (p.Ala9Asp) | single nucleotide variant | Malignant melanoma [RCV000063419] | Chr19:10315980 [GRCh38] Chr19:10426656 [GRCh37] Chr19:10287656 [NCBI36] Chr19:19p13.2 |
not provided |
NM_001103167.1(ZGLP1):c.355C>T (p.Pro119Ser) | single nucleotide variant | Malignant melanoma [RCV000071915] | Chr19:10308327 [GRCh38] Chr19:10419003 [GRCh37] Chr19:10280003 [NCBI36] Chr19:19p13.2 |
not provided |
GRCh38/hg38 19p13.2(chr19:9735443-11228001)x1 | copy number loss | See cases [RCV000135403] | Chr19:9735443..11228001 [GRCh38] Chr19:9846119..11338677 [GRCh37] Chr19:9707119..11199677 [NCBI36] Chr19:19p13.2 |
pathogenic |
GRCh38/hg38 19p13.2(chr19:10156406-10889688)x3 | copy number gain | See cases [RCV000136738] | Chr19:10156406..10889688 [GRCh38] Chr19:10267082..11000364 [GRCh37] Chr19:10128082..10861364 [NCBI36] Chr19:19p13.2 |
pathogenic |
NM_001031734.3(FDX2):c.-27_-25dup | microsatellite | not provided [RCV001719128] | Chr19:10316029..10316030 [GRCh38] Chr19:10426705..10426706 [GRCh37] Chr19:19p13.2 |
benign |
GRCh37/hg19 19p13.2-13.12(chr19:9678768-14853426) | copy number gain | See cases [RCV000446985] | Chr19:9678768..14853426 [GRCh37] Chr19:19p13.2-13.12 |
pathogenic |
GRCh37/hg19 19p13.2(chr19:10286133-11040457)x1 | copy number loss | See cases [RCV000446752] | Chr19:10286133..11040457 [GRCh37] Chr19:19p13.2 |
pathogenic |
NM_001397406.1(FDX2):c.201-14C>T | single nucleotide variant | not provided [RCV001512589]|not specified [RCV000434274] | Chr19:10315506 [GRCh38] Chr19:10426182 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.159T>G (p.Ala53=) | single nucleotide variant | Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy [RCV001702465]|not provided [RCV001523339]|not specified [RCV000423979] | Chr19:10315746 [GRCh38] Chr19:10426422 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.76A>G (p.Arg26Gly) | single nucleotide variant | not provided [RCV001523351]|not specified [RCV000441713] | Chr19:10315921 [GRCh38] Chr19:10315921..10315922 [GRCh38] Chr19:10426597 [GRCh37] Chr19:10426597..10426598 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.6C>A (p.Ala2=) | single nucleotide variant | FDX2-related disorder [RCV003972624]|not provided [RCV000906442] | Chr19:10315991 [GRCh38] Chr19:10426667 [GRCh37] Chr19:19p13.2 |
benign|likely benign |
NM_001397406.1(FDX2):c.498G>T (p.Leu166=) | single nucleotide variant | not provided [RCV000949048]|not specified [RCV000439004] | Chr19:10310540 [GRCh38] Chr19:10421216 [GRCh37] Chr19:19p13.2 |
benign |
NM_001031734.3(FDX2):c.-36C>T | single nucleotide variant | not specified [RCV000443619] | Chr19:10316041 [GRCh38] Chr19:10426717 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.145+16G>A | single nucleotide variant | not provided [RCV001522375]|not specified [RCV000422660] | Chr19:10315836 [GRCh38] Chr19:10426512 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.45A>G (p.Leu15=) | single nucleotide variant | Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy [RCV001702444]|not provided [RCV001523340]|not specified [RCV000440346] | Chr19:10315952 [GRCh38] Chr19:10426628 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.145+12G>C | single nucleotide variant | not provided [RCV002062444]|not specified [RCV000426742] | Chr19:10315840 [GRCh38] Chr19:10426516 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.441G>A (p.Ser147=) | single nucleotide variant | not provided [RCV001521710]|not specified [RCV000437284] | Chr19:10310597 [GRCh38] Chr19:10421273 [GRCh37] Chr19:19p13.2 |
benign|likely benign |
NM_001397406.1(FDX2):c.145+4C>T | single nucleotide variant | not provided [RCV001523350]|not specified [RCV000423555] | Chr19:10315848 [GRCh38] Chr19:10426524 [GRCh37] Chr19:19p13.2 |
benign |
NM_001031734.3(FDX2):c.-44C>T | single nucleotide variant | not specified [RCV000441179] | Chr19:10316049 [GRCh38] Chr19:10426725 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.201-23_201-13delinsCTTCT | indel | not specified [RCV000485772] | Chr19:10315505..10315515 [GRCh38] Chr19:10426181..10426191 [GRCh37] Chr19:19p13.2 |
likely benign |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)x3 | copy number gain | See cases [RCV000511289] | Chr19:260912..58956888 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic|uncertain significance |
NM_001397406.1(FDX2):c.83G>C (p.Gly28Ala) | single nucleotide variant | FDX2-related disorder [RCV003905653]|not provided [RCV001515027] | Chr19:10315914 [GRCh38] Chr19:10426590 [GRCh37] Chr19:19p13.2 |
benign|likely benign |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888) | copy number gain | See cases [RCV000512296] | Chr19:260912..58956888 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
NM_001397406.1(FDX2):c.40G>C (p.Val14Leu) | single nucleotide variant | FDX2-related disorder [RCV003953032]|not provided [RCV000895840] | Chr19:10315957 [GRCh38] Chr19:10426633 [GRCh37] Chr19:19p13.2 |
benign|likely benign |
NM_001031734.3(FDX2):c.-11T>C | single nucleotide variant | not specified [RCV000605135] | Chr19:10316016 [GRCh38] Chr19:10426692 [GRCh37] Chr19:19p13.2 |
likely benign |
GRCh37/hg19 19p13.3-q13.43(chr19:68029-59110290)x3 | copy number gain | not provided [RCV000752439] | Chr19:68029..59110290 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-59097160)x3 | copy number gain | not provided [RCV000752444] | Chr19:260912..59097160 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
NM_001397406.1(FDX2):c.308-269C>G | single nucleotide variant | not provided [RCV001583240] | Chr19:10311209 [GRCh38] Chr19:10421885 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.422C>T (p.Pro141Leu) | single nucleotide variant | Inborn mitochondrial myopathy [RCV000761588] | Chr19:10310616 [GRCh38] Chr19:10421292 [GRCh37] Chr19:19p13.2 |
pathogenic|likely pathogenic |
NM_001397406.1(FDX2):c.308-221G>C | single nucleotide variant | not provided [RCV001577236] | Chr19:10311161 [GRCh38] Chr19:10421837 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.201-8G>A | single nucleotide variant | not provided [RCV001581533] | Chr19:10315500 [GRCh38] Chr19:10426176 [GRCh37] Chr19:19p13.2 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_001397406.1(FDX2):c.471G>A (p.Pro157=) | single nucleotide variant | not provided [RCV001583322] | Chr19:10310567 [GRCh38] Chr19:10421243 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.201-17C>A | single nucleotide variant | not provided [RCV000827405] | Chr19:10315509 [GRCh38] Chr19:10426185 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.307+67_307+68insA | insertion | not provided [RCV001635786] | Chr19:10315318..10315319 [GRCh38] Chr19:10425994..10425995 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.396-67C>G | single nucleotide variant | not provided [RCV001534378] | Chr19:10310709 [GRCh38] Chr19:10421385 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.307+67_307+68insAA | insertion | not provided [RCV001581426] | Chr19:10315318..10315319 [GRCh38] Chr19:10425994..10425995 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.308-164T>C | single nucleotide variant | not provided [RCV001551148] | Chr19:10311104 [GRCh38] Chr19:10421780 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.307+64_307+66dup | duplication | not provided [RCV001559638] | Chr19:10315319..10315320 [GRCh38] Chr19:10425995..10425996 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.307+62_307+66dup | duplication | not provided [RCV001538772] | Chr19:10315319..10315320 [GRCh38] Chr19:10425995..10425996 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.307+38A>C | single nucleotide variant | not provided [RCV001595739] | Chr19:10315348 [GRCh38] Chr19:10426024 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.307+76T>C | single nucleotide variant | not provided [RCV001667363] | Chr19:10315310 [GRCh38] Chr19:10425986 [GRCh37] Chr19:19p13.2 |
benign |
NC_000019.10:g.10316099T>C | single nucleotide variant | not provided [RCV001586158] | Chr19:10316099 [GRCh38] Chr19:10426775 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.3G>T (p.Met1Ile) | single nucleotide variant | Inborn genetic diseases [RCV001265865] | Chr19:10315994 [GRCh38] Chr19:10426670 [GRCh37] Chr19:19p13.2 |
likely pathogenic |
NM_001397406.1(FDX2):c.105G>C (p.Glu35Asp) | single nucleotide variant | not provided [RCV002001920] | Chr19:10315892 [GRCh38] Chr19:10426568 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.299A>G (p.Asp100Gly) | single nucleotide variant | FDX2-related disorder [RCV003946162]|not provided [RCV001445297] | Chr19:10315394 [GRCh38] Chr19:10426070 [GRCh37] Chr19:19p13.2 |
likely benign|conflicting interpretations of pathogenicity |
NM_001397406.1(FDX2):c.307+67C>A | single nucleotide variant | not provided [RCV001670149] | Chr19:10315319 [GRCh38] Chr19:10425995 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.*180C>G | single nucleotide variant | not provided [RCV001715665] | Chr19:10310306 [GRCh38] Chr19:10420982 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.307+69del | deletion | not provided [RCV001611909] | Chr19:10315317 [GRCh38] Chr19:10425993 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.307+63_307+66dup | duplication | not provided [RCV001714302] | Chr19:10315319..10315320 [GRCh38] Chr19:10425995..10425996 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.307+68_307+69del | deletion | not provided [RCV001670415] | Chr19:10315317..10315318 [GRCh38] Chr19:10425993..10425994 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.307+66dup | duplication | not provided [RCV001762825] | Chr19:10315319..10315320 [GRCh38] Chr19:10425995..10425996 [GRCh37] Chr19:19p13.2 |
benign |
NM_001397406.1(FDX2):c.519C>G (p.Phe173Leu) | single nucleotide variant | not provided [RCV001864418] | Chr19:10310519 [GRCh38] Chr19:10421195 [GRCh37] Chr19:19p13.2 |
uncertain significance |
GRCh37/hg19 19p13.2(chr19:9941033-11739567)x3 | copy number gain | not provided [RCV001834267] | Chr19:9941033..11739567 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.-6C>T | single nucleotide variant | not provided [RCV002033902] | Chr19:10316002 [GRCh38] Chr19:10426678 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.106G>T (p.Gly36Trp) | single nucleotide variant | not provided [RCV002023813] | Chr19:10315891 [GRCh38] Chr19:10426567 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.470C>T (p.Pro157Leu) | single nucleotide variant | not provided [RCV002050966] | Chr19:10310568 [GRCh38] Chr19:10421244 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.145+6_145+14del | deletion | not provided [RCV001994057] | Chr19:10315838..10315846 [GRCh38] Chr19:10426514..10426522 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.456G>T (p.Gln152His) | single nucleotide variant | not provided [RCV002037407] | Chr19:10310582 [GRCh38] Chr19:10421258 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.142A>G (p.Thr48Ala) | single nucleotide variant | not provided [RCV002010760] | Chr19:10315855 [GRCh38] Chr19:10426531 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.178G>T (p.Gly60Cys) | single nucleotide variant | not provided [RCV002023337] | Chr19:10315727 [GRCh38] Chr19:10426403 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.146-2A>G | single nucleotide variant | not provided [RCV002002338] | Chr19:10315761 [GRCh38] Chr19:10426437 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.265A>G (p.Asn89Asp) | single nucleotide variant | not provided [RCV001958102] | Chr19:10315428 [GRCh38] Chr19:10426104 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.165GGA[1] (p.Glu56del) | microsatellite | not provided [RCV001928719] | Chr19:10315735..10315737 [GRCh38] Chr19:10426411..10426413 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.22G>A (p.Gly8Arg) | single nucleotide variant | not provided [RCV001893261] | Chr19:10315975 [GRCh38] Chr19:10426651 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.146-16G>T | single nucleotide variant | not provided [RCV002116555] | Chr19:10315775 [GRCh38] Chr19:10426451 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.145+19G>A | single nucleotide variant | not provided [RCV002107911] | Chr19:10315833 [GRCh38] Chr19:10426509 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.492C>T (p.Phe164=) | single nucleotide variant | not provided [RCV002148693] | Chr19:10310546 [GRCh38] Chr19:10421222 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.21G>C (p.Arg7=) | single nucleotide variant | not provided [RCV002162302] | Chr19:10315976 [GRCh38] Chr19:10426652 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.201-13C>T | single nucleotide variant | not provided [RCV002151842] | Chr19:10315505 [GRCh38] Chr19:10426181 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.315T>C (p.Cys105=) | single nucleotide variant | not provided [RCV002095070] | Chr19:10310933 [GRCh38] Chr19:10421609 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.201-23_201-18del | deletion | not provided [RCV002155772] | Chr19:10315510..10315515 [GRCh38] Chr19:10426186..10426191 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.117G>A (p.Leu39=) | single nucleotide variant | not provided [RCV003110270] | Chr19:10315880 [GRCh38] Chr19:10426556 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.402C>T (p.Asp134=) | single nucleotide variant | not provided [RCV003110318] | Chr19:10310636 [GRCh38] Chr19:10421312 [GRCh37] Chr19:19p13.2 |
likely benign |
NC_000019.9:g.(?_10421162)_(10426681_?)del | deletion | not provided [RCV003122331] | Chr19:10421162..10426681 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.175G>A (p.Gly59Ser) | single nucleotide variant | not provided [RCV002297303] | Chr19:10315730 [GRCh38] Chr19:10426406 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.149C>T (p.Ser50Leu) | single nucleotide variant | not provided [RCV002904750] | Chr19:10315756 [GRCh38] Chr19:10426432 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.395+19T>A | single nucleotide variant | not provided [RCV002776401] | Chr19:10310834 [GRCh38] Chr19:10421510 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.462G>A (p.Val154=) | single nucleotide variant | not provided [RCV002690434] | Chr19:10310576 [GRCh38] Chr19:10421252 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.403G>A (p.Asp135Asn) | single nucleotide variant | not provided [RCV002617837] | Chr19:10310635 [GRCh38] Chr19:10421311 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.521A>T (p.Tyr174Phe) | single nucleotide variant | not provided [RCV003014038] | Chr19:10310517 [GRCh38] Chr19:10421193 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.109dup (p.Val37fs) | duplication | not provided [RCV002776408] | Chr19:10315887..10315888 [GRCh38] Chr19:10426563..10426564 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.523G>A (p.Val175Met) | single nucleotide variant | not provided [RCV002615862] | Chr19:10310515 [GRCh38] Chr19:10421191 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.442C>T (p.Arg148Trp) | single nucleotide variant | not provided [RCV002592814] | Chr19:10310596 [GRCh38] Chr19:10421272 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.255A>G (p.Arg85=) | single nucleotide variant | not provided [RCV002662932] | Chr19:10315438 [GRCh38] Chr19:10426114 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.496C>T (p.Leu166=) | single nucleotide variant | not provided [RCV002885807] | Chr19:10310542 [GRCh38] Chr19:10421218 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.307+13C>G | single nucleotide variant | not provided [RCV002639940] | Chr19:10315373 [GRCh38] Chr19:10426049 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.231C>T (p.Gly77=) | single nucleotide variant | not provided [RCV002622615] | Chr19:10315462 [GRCh38] Chr19:10426138 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.114G>C (p.Ala38=) | single nucleotide variant | not provided [RCV002623581] | Chr19:10315883 [GRCh38] Chr19:10426559 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.219A>G (p.Val73=) | single nucleotide variant | not provided [RCV002643210] | Chr19:10315474 [GRCh38] Chr19:10426150 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.146-13C>T | single nucleotide variant | not provided [RCV002574833] | Chr19:10315772 [GRCh38] Chr19:10426448 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.405C>T (p.Asp135=) | single nucleotide variant | not provided [RCV002574878] | Chr19:10310633 [GRCh38] Chr19:10421309 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.159T>C (p.Ala53=) | single nucleotide variant | not provided [RCV002666627] | Chr19:10315746 [GRCh38] Chr19:10426422 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.539C>G (p.Pro180Arg) | single nucleotide variant | not provided [RCV002573736] | Chr19:10310499 [GRCh38] Chr19:10421175 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.465G>C (p.Leu155=) | single nucleotide variant | not provided [RCV003059493] | Chr19:10310573 [GRCh38] Chr19:10421249 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.141G>A (p.Ala47=) | single nucleotide variant | not provided [RCV002575157] | Chr19:10315856 [GRCh38] Chr19:10426532 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.308-6C>T | single nucleotide variant | not provided [RCV002805465] | Chr19:10310946 [GRCh38] Chr19:10421622 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.201-14C>G | single nucleotide variant | not provided [RCV002572630] | Chr19:10315506 [GRCh38] Chr19:10426182 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.443G>A (p.Arg148Gln) | single nucleotide variant | not provided [RCV002800676] | Chr19:10310595 [GRCh38] Chr19:10421271 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.55G>A (p.Ala19Thr) | single nucleotide variant | not provided [RCV002700829] | Chr19:10315942 [GRCh38] Chr19:10426618 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.256G>A (p.Val86Ile) | single nucleotide variant | not provided [RCV002631015] | Chr19:10315437 [GRCh38] Chr19:10426113 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.307+5G>A | single nucleotide variant | not provided [RCV003048614] | Chr19:10315381 [GRCh38] Chr19:10426057 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.175G>T (p.Gly59Cys) | single nucleotide variant | not provided [RCV003046182] | Chr19:10315730 [GRCh38] Chr19:10426406 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.120G>C (p.Gly40=) | single nucleotide variant | not provided [RCV002578121] | Chr19:10315877 [GRCh38] Chr19:10426553 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.146-10T>A | single nucleotide variant | not provided [RCV003047033] | Chr19:10315769 [GRCh38] Chr19:10426445 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.13A>G (p.Met5Val) | single nucleotide variant | not provided [RCV003088781] | Chr19:10315984 [GRCh38] Chr19:10426660 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.201-18A>G | single nucleotide variant | not provided [RCV002716931] | Chr19:10315510 [GRCh38] Chr19:10426186 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.72G>A (p.Trp24Ter) | single nucleotide variant | not provided [RCV003048162] | Chr19:10315925 [GRCh38] Chr19:10426601 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.153C>T (p.Arg51=) | single nucleotide variant | not provided [RCV003043712] | Chr19:10315752 [GRCh38] Chr19:10426428 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.57C>T (p.Ala19=) | single nucleotide variant | not provided [RCV002631397] | Chr19:10315940 [GRCh38] Chr19:10426616 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.396-15G>A | single nucleotide variant | not provided [RCV002601255] | Chr19:10310657 [GRCh38] Chr19:10421333 [GRCh37] Chr19:19p13.2 |
likely benign|uncertain significance |
NM_001397406.1(FDX2):c.416T>C (p.Met139Thr) | single nucleotide variant | not provided [RCV003008481] | Chr19:10310622 [GRCh38] Chr19:10421298 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.200+15C>G | single nucleotide variant | not provided [RCV002671956] | Chr19:10315690 [GRCh38] Chr19:10426366 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.460G>A (p.Val154Met) | single nucleotide variant | not provided [RCV002721952] | Chr19:10310578 [GRCh38] Chr19:10421254 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.420C>T (p.Ala140=) | single nucleotide variant | not provided [RCV002604906] | Chr19:10310618 [GRCh38] Chr19:10421294 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.200+12G>A | single nucleotide variant | not provided [RCV002635820] | Chr19:10315693 [GRCh38] Chr19:10426369 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.12C>T (p.Ser4=) | single nucleotide variant | not provided [RCV002604946] | Chr19:10315985 [GRCh38] Chr19:10426661 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.308-11C>T | single nucleotide variant | not provided [RCV002635144] | Chr19:10310951 [GRCh38] Chr19:10421627 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.486G>A (p.Ala162=) | single nucleotide variant | not provided [RCV003067492] | Chr19:10310552 [GRCh38] Chr19:10421228 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.47T>C (p.Leu16Pro) | single nucleotide variant | not provided [RCV002586573] | Chr19:10315950 [GRCh38] Chr19:10426626 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.20G>A (p.Arg7Gln) | single nucleotide variant | not provided [RCV002943606] | Chr19:10315977 [GRCh38] Chr19:10426653 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.386C>T (p.Pro129Leu) | single nucleotide variant | not provided [RCV002587920] | Chr19:10310862 [GRCh38] Chr19:10421538 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.35C>T (p.Ala12Val) | single nucleotide variant | not provided [RCV002610465] | Chr19:10315962 [GRCh38] Chr19:10426638 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.16G>A (p.Ala6Thr) | single nucleotide variant | not provided [RCV002604638] | Chr19:10315981 [GRCh38] Chr19:10426657 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.201-20G>T | single nucleotide variant | not provided [RCV002586233] | Chr19:10315512 [GRCh38] Chr19:10426188 [GRCh37] Chr19:19p13.2 |
likely benign|uncertain significance |
NM_001397406.1(FDX2):c.271C>T (p.Leu91Phe) | single nucleotide variant | not provided [RCV003480297] | Chr19:10315422 [GRCh38] Chr19:10426098 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.135T>C (p.Phe45=) | single nucleotide variant | not provided [RCV003545947] | Chr19:10315862 [GRCh38] Chr19:10426538 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.146-20C>T | single nucleotide variant | not provided [RCV003696521] | Chr19:10315779 [GRCh38] Chr19:10426455 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.111G>A (p.Val37=) | single nucleotide variant | not provided [RCV003713462] | Chr19:10315886 [GRCh38] Chr19:10426562 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.150G>T (p.Ser50=) | single nucleotide variant | not provided [RCV003875959] | Chr19:10315755 [GRCh38] Chr19:10426431 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.200+4A>G | single nucleotide variant | Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy [RCV003761180] | Chr19:10315701 [GRCh38] Chr19:10426377 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.145+17G>C | single nucleotide variant | not provided [RCV003811904] | Chr19:10315835 [GRCh38] Chr19:10426511 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.114G>A (p.Ala38=) | single nucleotide variant | not provided [RCV003668664] | Chr19:10315883 [GRCh38] Chr19:10426559 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.146-16G>C | single nucleotide variant | not provided [RCV003838902] | Chr19:10315775 [GRCh38] Chr19:10426451 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.209T>C (p.Val70Ala) | single nucleotide variant | not provided [RCV003838773] | Chr19:10315484 [GRCh38] Chr19:10426160 [GRCh37] Chr19:19p13.2 |
uncertain significance |
NM_001397406.1(FDX2):c.307+13C>T | single nucleotide variant | not provided [RCV003863853] | Chr19:10315373 [GRCh38] Chr19:10426049 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.-4T>C | single nucleotide variant | not provided [RCV003708367] | Chr19:10316000 [GRCh38] Chr19:10426676 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.216C>T (p.Phe72=) | single nucleotide variant | not provided [RCV003731312] | Chr19:10315477 [GRCh38] Chr19:10426153 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.387C>T (p.Pro129=) | single nucleotide variant | not provided [RCV003563486] | Chr19:10310861 [GRCh38] Chr19:10421537 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.447G>C (p.Leu149=) | single nucleotide variant | not provided [RCV003841747] | Chr19:10310591 [GRCh38] Chr19:10421267 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.330C>G (p.Ala110=) | single nucleotide variant | not provided [RCV003718959] | Chr19:10310918 [GRCh38] Chr19:10421594 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.159T>A (p.Ala53=) | single nucleotide variant | not provided [RCV003684814] | Chr19:10315746 [GRCh38] Chr19:10426422 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.318A>G (p.Glu106=) | single nucleotide variant | not provided [RCV003862963] | Chr19:10310930 [GRCh38] Chr19:10421606 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.396-16C>T | single nucleotide variant | not provided [RCV003844257] | Chr19:10310658 [GRCh38] Chr19:10421334 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.189G>T (p.Arg63=) | single nucleotide variant | not provided [RCV003856955] | Chr19:10315716 [GRCh38] Chr19:10426392 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.114G>T (p.Ala38=) | single nucleotide variant | not provided [RCV003542048] | Chr19:10315883 [GRCh38] Chr19:10426559 [GRCh37] Chr19:19p13.2 |
likely benign |
NM_001397406.1(FDX2):c.9C>T (p.Ala3=) | single nucleotide variant | FDX2-related disorder [RCV003897416] | Chr19:10315988 [GRCh38] Chr19:10426664 [GRCh37] Chr19:19p13.2 |
likely benign |
NC_000019.9:g.(?_10244343)_(11231218_?)del | deletion | Familial hypercholesterolemia [RCV004581010] | Chr19:10244343..11231218 [GRCh37] Chr19:19p13.2 |
pathogenic |
NC_000019.9:g.(?_10244343)_(10610709_?)del | deletion | Immunodeficiency 35 [RCV004581090] | Chr19:10244343..10610709 [GRCh37] Chr19:19p13.2 |
pathogenic |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
The following QTLs overlap with this region. | Full Report | CSV | TAB | Printer | Gviewer |
WI-14289 |
|
||||||||||||||||||||||||||||||||||||||||
RH48407 |
|
Ensembl Acc Id: | ENST00000343376 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000393708 ⟹ ENSP00000377311 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000453681 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000460631 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000486454 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000492239 ⟹ ENSP00000488228 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000494368 ⟹ ENSP00000467188 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000706663 ⟹ ENSP00000516489 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001397406 ⟹ NP_001384335 | ||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||
Type: | CODING | ||||||||||||
Position: |
|
Protein RefSeqs | NP_001026904 | (Get FASTA) | NCBI Sequence Viewer |
NP_001384335 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAH63460 | (Get FASTA) | NCBI Sequence Viewer |
BAH13303 | (Get FASTA) | NCBI Sequence Viewer | |
Ensembl Protein | ENSP00000377311 | ||
ENSP00000377311.5 | |||
ENSP00000467188.1 | |||
ENSP00000488228.1 | |||
ENSP00000516489.1 | |||
GenBank Protein | Q6P4F2 | (Get FASTA) | NCBI Sequence Viewer |
Ensembl Acc Id: | ENSP00000488228 ⟸ ENST00000492239 |
Ensembl Acc Id: | ENSP00000467188 ⟸ ENST00000494368 |
Ensembl Acc Id: | ENSP00000377311 ⟸ ENST00000393708 |
RefSeq Acc Id: | NP_001384335 ⟸ NM_001397406 |
- UniProtKB: | B7Z6L7 (UniProtKB/Swiss-Prot), Q8N8B8 (UniProtKB/Swiss-Prot), Q6P4F2 (UniProtKB/Swiss-Prot) |
Ensembl Acc Id: | ENSP00000516489 ⟸ ENST00000706663 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q6P4F2-F1-model_v2 | AlphaFold | Q6P4F2 | 1-186 | view protein structure |
RGD ID: | 6795565 | ||||||||
Promoter ID: | HG_KWN:28843 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | NB4 | ||||||||
Transcripts: | ENST00000403352, ENST00000403903 | ||||||||
Position: |
|
RGD ID: | 6795560 | ||||||||
Promoter ID: | HG_KWN:28844 | ||||||||
Type: | Non-CpG | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | NB4 | ||||||||
Transcripts: | OTTHUMT00000325277 | ||||||||
Position: |
|
RGD ID: | 6795564 | ||||||||
Promoter ID: | HG_KWN:28845 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | ENST00000343376, OTTHUMT00000280567, OTTHUMT00000325270, OTTHUMT00000325271, OTTHUMT00000325272, OTTHUMT00000325273, OTTHUMT00000325274, OTTHUMT00000325275, OTTHUMT00000325276, UC002MNX.1 | ||||||||
Position: |
|
RGD ID: | 7238483 | ||||||||
Promoter ID: | EPDNEW_H24986 | ||||||||
Type: | initiation region | ||||||||
Name: | FDX1L_1 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:30546 | AgrOrtholog |
COSMIC | FDX2 | COSMIC |
Ensembl Genes | ENSG00000267673 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Ensembl Transcript | ENST00000393708 | ENTREZGENE |
ENST00000393708.3 | UniProtKB/Swiss-Prot | |
ENST00000492239.5 | UniProtKB/TrEMBL | |
ENST00000494368.5 | UniProtKB/TrEMBL | |
ENST00000706663.1 | UniProtKB/TrEMBL | |
Gene3D-CATH | 3.10.20.30 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
GTEx | ENSG00000267673 | GTEx |
HGNC ID | HGNC:30546 | ENTREZGENE |
Human Proteome Map | FDX2 | Human Proteome Map |
InterPro | 2Fe-2S_ferredoxin-like_sf | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
2Fe-2S_ferredoxin-type | UniProtKB/Swiss-Prot | |
Adrenodoxin | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Adrenodoxin_Fe-S_BS | UniProtKB/Swiss-Prot | |
Beta-grasp_dom_sf | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
NCBI Gene | FDX2 | ENTREZGENE |
OMIM | 614585 | OMIM |
PANTHER | FERREDOXIN-2, MITOCHONDRIAL | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PTHR23426 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | Fer2 | UniProtKB/Swiss-Prot |
PharmGKB | PA162388212 | PharmGKB |
PRINTS | ADRENODOXIN | UniProtKB/Swiss-Prot |
PROSITE | 2FE2S_FER_2 | UniProtKB/Swiss-Prot |
ADX | UniProtKB/Swiss-Prot | |
Superfamily-SCOP | SSF54292 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
UniProt | A0A0A0MTS8_HUMAN | UniProtKB/TrEMBL |
A0A9L9PXQ6_HUMAN | UniProtKB/TrEMBL | |
B7Z6L7 | ENTREZGENE | |
FDX2_HUMAN | UniProtKB/Swiss-Prot, ENTREZGENE | |
Q8N8B8 | ENTREZGENE | |
UniProt Secondary | B7Z6L7 | UniProtKB/Swiss-Prot |
Q8N8B8 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2018-04-10 | FDX2 | ferredoxin 2 | FDX1L | ferredoxin 1 like | Symbol and/or name change | 5135510 | APPROVED |
2016-05-17 | FDX1L | ferredoxin 1 like | ferredoxin 1-like | Symbol and/or name change | 5135510 | APPROVED |